Zyversa Therapeutics Inc.

04/09/2025 | Press release | Distributed by Public on 04/10/2025 04:01

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 9, 2025 5:00 P.M.
Form: S-3
CIK: 0001859007
Company Name: ZyVersa Therapeutics, Inc.
File Number: 333-286396
Zyversa Therapeutics Inc. published this content on April 09, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on April 10, 2025 at 10:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]